Halozyme (HALO) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Halozyme · Health Care · ref. ETF XLV · 57 calls · price $106.92
What the company does: Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.
📈 Halozyme (HALO) stock price
$106.92+46.8% over range
Aug 28, 25low $61.63 · high $109.32Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
📊 JPI status : Halozyme is no longer in our current JPI rankings, but appeared in the past (2021) — its upside may be behind it. See the stocks picked in 2021 →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 HALO price target & analyst consensus — price $107
The price target · all analysts combined (6 targets)
Highest target · 1 firm of 6$115+7.6%
Median target · of 6 targets$100-6.5%
Lowest target · 2 firms of 6$93-13.0%
Current price$106.92
Where these 6 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
233%
$110 ↔ $115
Below
467%
$93 ↔ $105
⏳ Targets haven't kept up with the price. 83% of ratings say “Buy”, yet 4 of 6 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: HC Wainwright & Co. — 70% of its targets hit on this sector (238 calls tested). It aims for $115 (+7.6 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).
The 3 reliable analysts
$105-1.8 %
The 3 other firms
$93-13 %
How to read it: the 3 reliable firms are not filtered by optimism — 1 aim above the price, 2 below, hence their $105 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 6 ratings (last 6 months)
Strong Buy00%
Buy583%
Hold117%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HALO price target all
All 57 calls, one by one, with our verdict on each firm.
→ See all 57 targets, analyst by analyst💡 The best analysts on HALO most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HALO? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Halozyme? The JPI assistant answers using our backtest data.
📈 Halozyme fundamentals: valuation, margins & growth › open the full page
P/E 31.4Net margin 24.9 %Revenue growth +47.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 31 %
2023
Rev +26%Profit +39%
2024
Rev +22%Profit +58%
2025
Rev +38%Profit −29%
🔎 Detailed analyses
✅ Historical analyst reliability on HALO
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Piper Sandler ↗ | 100% | +57.4% | 5 |
| HC Wainwright & Co. ↗ | 100% | +32.9% | 37 |
| TD Cowen ↗ | 100% | +32.0% | 2 |
| Barclays ↗ | 83% | +47.2% | 6 |
| BMO Capital ↗ | 80% | +75.9% | 5 |
| Cantor Fitzgerald ↗ | 75% | +86.6% | 4 |
| Benchmark ↗ | 75% | +30.3% | 8 |
| JP Morgan ↗ | 70% | +53.4% | 10 |
| Canaccord Genuity ↗ | 67% | +31.9% | 3 |
| Wells Fargo ↗ | 67% | +9.6% | 6 |
See the other 7 firms
| Jefferies ↗ | 0% | -52.8% | 4 |
| SVB Leerink | 50% | -8.9% | 4 |
| Wedbush ↗ | 50% | +11.5% | 2 |
| Citigroup ↗ | 50% | +41.6% | 2 |
| Goldman Sachs ↗ | 50% | +57.2% | 2 |
| Morgan Stanley ↗ | 60% | +13.0% | 10 |
| JMP Securities | 64% | +18.5% | 14 |
📊 What $1,000 invested in Halozyme would be worth › open the full page
In short — $1,000 invested in Halozyme 10 years ago would be worth $4,516 today, i.e. +16%/yr on average. Best year: 2020 (+141%), worst: 2016 (-43%). Price performance, excluding dividends.
If I'd invested $1,000 in Halozyme
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,637 | +64% |
| 3 years ago | $1,376 | +38% |
| 5 years ago | $1,833 | +83% |
Return by year (Halozyme)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +16% | $1,163 (+16%) |
| 2025 | +41% | $1,637 (+64%) |
| 2024 | +29% | $2,118 (+112%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Halozyme
Loading news…
📋 All analyst calls on HALO
Filtered on — · ✕ show all
Leerink Partners ↗
Aug 8, 26
▲ Outperform · 🎯$110
Price at call : $102.62 — upside +7%
Today : $106.92 — upside +3%
🎯 on HALO : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Aug 8, 27
matures : Aug 8, 27
▲ Buy · 🎯$105
Price at call : $102.62 — upside +2%
Today : $106.92 — upside -2%
🎯 on HALO : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Citizens
Aug 7, 26
▲ Market Outperform · 🎯$93
Price at call : $102.62 — upside -9%
Today : $106.92 — upside -13%
🎯 on HALO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Wells Fargo ↗
Aug 7, 26
■ Equal-Weight neutral · not a buy · 🎯$95
Price at call : $102.62 — gap to target -7%
Today : $106.92 — gap to target -11%
🎯 on HALO : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
HC Wainwright & Co. ↗
Aug 7, 26
▲ Buy · 🎯$115
Price at call : $103.12 — upside +12%
Today : $106.92 — upside +8%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
HC Wainwright & Co. ↗
Jul 21, 26
▲ Buy · 🎯$95
Price at call : $78.6 — upside +21%
Today : $106.92 — upside -11%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Jul 21, 27
matures : Jul 21, 27
Morgan Stanley ↗
May 12, 26
▲ Overweight · 🎯$93
Price at call : $70.03 — upside +33%
Today : $106.92 — upside -13%
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
HC Wainwright & Co. ↗
Apr 29, 26
▲ Buy · 🎯$95
Price at call : $63.06 — upside +51%
Today : $106.92 — upside -11%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
See the other 49 calls, newest to oldest
▲ Buy · 🎯$90
Price at call : $70.98 — upside +27%
Today : $106.92 — upside -16%
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
in progress (365j)
matures : Feb 19, 27
matures : Feb 19, 27
Wells Fargo ↗
Feb 19, 26
■ Equal-Weight neutral · not a buy · 🎯$75
Price at call : $72.04 — gap to target +4%
Today : $106.92 — gap to target -30%
🎯 on HALO : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 19, 27
matures : Feb 19, 27
▲ Buy · 🎯$90
Price at call : $72.47 — upside +24%
Today : $106.92 — upside -16%
🎯 on HALO : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
HC Wainwright & Co. ↗
Dec 19, 25
▲ Buy · 🎯$90
Price at call : $67.35 — upside +34%
Today : $106.92 — upside -16%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
HC Wainwright & Co. ↗
Nov 28, 25
▲ Buy · 🎯$90
Price at call : $71.4 — upside +26%
Today : $106.92 — upside -16%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Nov 28, 26
matures : Nov 28, 26
Goldman Sachs ↗
Nov 18, 25
■ Neutral neutral · not a buy · 🎯$56
Price at call : $70.25 — gap to target -20%
Today : $106.92 — gap to target -48%
🎯 on HALO : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
Citizens
Nov 4, 25
▲ Market Outperform · 🎯$92
Price at call : $68.05 — upside +35%
Today : $106.92 — upside -14%
🎯 on HALO : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
■ Neutral neutral · not a buy · 🎯$65
Price at call : $65.4 — gap to target -1%
Today : $106.92 — gap to target -39%
🎯 on HALO : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
Morgan Stanley ↗
Oct 20, 25
▲ Overweight · 🎯$79
Price at call : $66.88 — upside +18%
Today : $106.92 — upside -26%
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Oct 20, 26
matures : Oct 20, 26
HC Wainwright & Co. ↗
Oct 15, 25
▲ Buy · 🎯$90
Price at call : $66.36 — upside +36%
Today : $106.92 — upside -16%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
Leerink Partners ↗
Oct 14, 25
■ Market Perform neutral · not a buy · 🎯$70
Price at call : $66.36 — gap to target +5%
Today : $106.92 — gap to target -35%
🎯 on HALO : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
HC Wainwright & Co. ↗
Oct 2, 25
▲ Buy · 🎯$90
Price at call : $71.69 — upside +26%
Today : $106.92 — upside -16%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Oct 2, 26
matures : Oct 2, 26
▲ Buy · 🎯$90
Price at call : $75.64 — upside +19%
Today : $106.92 — upside -16%
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
HC Wainwright & Co. ↗
Sep 22, 25
▲ Buy · 🎯$85
Price at call : $78.28 — upside +9%
Today : $106.92 — upside -21%
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Sep 22, 26
matures : Sep 22, 26
Morgan Stanley ↗
Aug 18, 25
▲ Overweight · 🎯$80
Price at call : $68.96 — upside +16%
Today : $106.92 — upside -25%
Expected +16% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+52.1%
stock +52% · XLV +25%
matured Aug 18, 26
■ Neutral neutral · not a buy · 🎯$63
Price at call : $62.9 — gap to target +0%
Today : $106.92 — gap to target -41%
🎯 on HALO : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 7, 26
matures : Aug 7, 26
JMP Securities
Aug 6, 25
▲ Market Outperform · 🎯$91
Price at call : $62.1 — upside +47%
Today : $106.92 — upside -15%
Expected +47% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (2 calls matureds) · 📊 unranked overall
+66.0%
stock +66% · XLV +28%
matured Aug 6, 26
HC Wainwright & Co. ↗
Aug 6, 25
▲ Buy · 🎯$75
Price at call : $62.32 — upside +20%
Today : $106.92 — upside -30%
Expected +20% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+37.6%
stock +38% · XLV +26%
matured Aug 6, 26
Morgan Stanley ↗
Aug 6, 25
▲ Overweight · 🎯$75
Price at call : $62.32 — upside +20%
Today : $106.92 — upside -30%
Expected +20% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
+37.6%
stock +38% · XLV +26%
matured Aug 6, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $57.81 — gap to target +4%
Today : $106.92 — gap to target -44%
🎯 on HALO : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jul 16, 26
matures : Jul 16, 26
HC Wainwright & Co. ↗
May 29, 25
▲ Buy · 🎯$72
Price at call : $54.73 — upside +32%
Today : $106.92 — upside -33%
Expected +32% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+21.6%
stock +22% · XLV +13%
matured May 29, 26
Morgan Stanley ↗
May 14, 25
■ Equal-Weight neutral · not a buy · 🎯$62
Price at call : $48.95 — gap to target +27%
Today : $106.92 — gap to target -42%
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : May 14, 26
matures : May 14, 26
Leerink Partners ↗
May 13, 25
▼ Underperform · 🎯$47
Price at call : $47.91 — upside -2%
Today : $106.92 — upside -56%
Expected -2% · Actual +44% · Reason (≤ −15%) : ✗ No
🎯 on HALO : 0% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
-44.5%
stock +44% · XLV +14%
matured May 13, 26
Morgan Stanley ↗
May 7, 25
▲ Overweight · 🎯$73
Price at call : $67.73 — upside +8%
Today : $106.92 — upside -32%
Expected +8% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 67% (3 calls matureds) · 📊 on Health : 41.3% · -1.5% (196 calls)
-5.3%
stock -5% · XLV +7%
matured May 7, 26
Wells Fargo ↗
May 7, 25
■ Equal-Weight neutral · not a buy · 🎯$65
Price at call : $67.73 — gap to target -4%
Today : $106.92 — gap to target -39%
🎯 on HALO : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : May 7, 26
matures : May 7, 26
HC Wainwright & Co. ↗
Apr 25, 25
▲ Buy · 🎯$72
Price at call : $60.49 — upside +19%
Today : $106.92 — upside -33%
Expected +19% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+6.6%
stock +7% · XLV +4%
matured Apr 25, 26
■ Neutral neutral · not a buy · 🎯$58
Price at call : $58.21 — gap to target -0%
Today : $106.92 — gap to target -46%
🎯 on HALO : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Apr 21, 26
matures : Apr 21, 26
HC Wainwright & Co. ↗
Mar 6, 25
▲ Buy
Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+12.0%
stock +12% · XLV +2%
matured Mar 6, 26
▲ Buy · 🎯$75
Price at call : $57.44 — upside +31%
Today : $106.92 — upside -30%
Expected +31% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
+23.6%
stock +24% · XLV +7%
matured Feb 20, 26
HC Wainwright & Co. ↗
Feb 19, 25
▲ Buy · 🎯$72
Price at call : $57.77 — upside +25%
Today : $106.92 — upside -33%
Expected +25% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+24.7%
stock +25% · XLV +7%
matured Feb 19, 26
HC Wainwright & Co. ↗
Feb 4, 25
▲ Buy · 🎯$70
Price at call : $56.77 — upside +23%
Today : $106.92 — upside -35%
Expected +23% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+37.3%
stock +37% · XLV +6%
matured Feb 4, 26
Wells Fargo ↗
Jan 13, 25
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $53.83 — gap to target +6%
Today : $106.92 — gap to target -47%
🎯 on HALO : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jan 13, 26
matures : Jan 13, 26
Piper Sandler ↗
Jan 10, 25
■ Neutral neutral · not a buy · 🎯$53
Price at call : $54.14 — gap to target -2%
Today : $106.92 — gap to target -50%
🎯 on HALO : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 10, 26
matures : Jan 10, 26
HC Wainwright & Co. ↗
Jan 10, 25
▲ Buy · 🎯$70
Price at call : $52.8 — upside +33%
Today : $106.92 — upside -35%
Expected +33% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+37.2%
stock +37% · XLV +13%
matured Jan 10, 26
HC Wainwright & Co. ↗
Dec 30, 24
▲ Buy · 🎯$68
Price at call : $47.99 — upside +42%
Today : $106.92 — upside -36%
Expected +42% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+41.1%
stock +41% · XLV +13%
matured Dec 30, 25
HC Wainwright & Co. ↗
Dec 18, 24
▲ Buy · 🎯$68
Price at call : $46.84 — upside +45%
Today : $106.92 — upside -36%
Expected +45% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+39.0%
stock +39% · XLV +12%
matured Dec 18, 25
HC Wainwright & Co. ↗
Nov 25, 24
▲ Buy · 🎯$68
Price at call : $47.79 — upside +42%
Today : $106.92 — upside -36%
Expected +42% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+52.4%
stock +52% · XLV +9%
matured Nov 25, 25
HC Wainwright & Co. ↗
Nov 20, 24
▲ Buy · 🎯$68
Price at call : $45.7 — upside +49%
Today : $106.92 — upside -36%
Expected +49% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+53.9%
stock +54% · XLV +7%
matured Nov 20, 25
Piper Sandler ↗
Nov 4, 24
■ Neutral neutral · not a buy · 🎯$52
Price at call : $58.72 — gap to target -11%
Today : $106.92 — gap to target -51%
🎯 on HALO : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Nov 4, 25
matures : Nov 4, 25
JMP Securities
Nov 1, 24
▲ Market Outperform · 🎯$73
Price at call : $57.15 — upside +28%
Today : $106.92 — upside -32%
Expected +28% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (2 calls matureds) · 📊 unranked overall
+15.8%
stock +16% · XLV -2%
matured Nov 1, 25
HC Wainwright & Co. ↗
Nov 1, 24
▲ Buy · 🎯$68
Price at call : $57.15 — upside +19%
Today : $106.92 — upside -36%
Expected +19% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+15.8%
stock +16% · XLV -2%
matured Nov 1, 25
HC Wainwright & Co. ↗
Oct 25, 24
▲ Buy · 🎯$65
Price at call : $49.25 — upside +32%
Today : $106.92 — upside -39%
Expected +32% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 100% (13 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+33.7%
stock +34% · XLV -1%
matured Oct 25, 25
▲ Buy · 🎯$60
Price at call : $55.2 — upside +9%
Today : $106.92 — upside -44%
Expected +9% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
+13.9%
stock +14% · XLV -13%
matured Aug 8, 25
▲ Buy · 🎯$60
Price at call : $52.4 — upside +15%
Today : $106.92 — upside -44%
Expected +15% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
-0.1%
stock -0% · XLV -9%
matured Jun 25, 25
▲ Buy · 🎯$50
Price at call : $38.38 — upside +30%
Today : $106.92 — upside -53%
Expected +30% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
+53.3%
stock +53% · XLV -2%
matured Apr 16, 25
▲ Buy · 🎯$50
Price at call : $34.01 — upside +47%
Today : $106.92 — upside -53%
Expected +47% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
+64.5%
stock +64% · XLV +2%
matured Jan 18, 25
▲ Buy · 🎯$50
Price at call : $34.77 — upside +44%
Today : $106.92 — upside -53%
Expected +44% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
+48.9%
stock +49% · XLV +19%
matured Oct 19, 24
▲ Buy · 🎯$68
Price at call : $57.85 — upside +18%
Today : $106.92 — upside -36%
Expected +18% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on HALO : 75% (8 calls matureds) · 📊 on Health : 70% · +18.4% (10 calls)
-30.9%
stock -31% · XLV -6%
matured Dec 8, 23
Frequently asked questions
Should I buy Halozyme stock?
This isn't buy advice. For Halozyme, the analyst consensus is "Buy", with an average price target of $100 (-6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Halozyme). We show the numbers — you decide.
Is it too late to buy Halozyme? How high can it go?
The most bullish analyst target on Halozyme is $115 (+8% above today's price); the average is $100. That's the upside they see. Check how reliable those analysts have actually been on Halozyme on our site before trusting it.
Is Halozyme still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Halozyme, the best hitting 100% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Halozyme? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HALO (and why hesitate).
What has Halozyme's past performance been?
Historical returns and a "how much if I had invested" calculator: HALO performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX